Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial

Hepatology ◽  
2009 ◽  
Vol 51 (2) ◽  
pp. 445-453 ◽  
Author(s):  
Vlad Ratziu ◽  
Fréderic Charlotte ◽  
Carole Bernhardt ◽  
Philippe Giral ◽  
Marine Halbron ◽  
...  
Keyword(s):  
Fatty Liver ◽  
Nonalcoholic Steatohepatitis ◽  
Term Efficacy ◽  
Extension Trial

scholarly journals The Long-term Efficacy of Sodium Glucose Co-transporter 2 Inhibitor in Patients with Non-alcoholic Fatty Liver Disease

2019 ◽  
Vol 58 (14) ◽  
pp. 1987-1992 ◽  
Author(s):  
Mio Yamashima ◽  
Hisamitsu Miyaaki ◽  
Satoshi Miuma ◽  
Hidetaka Shibata ◽  
Ryu Sasaki ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Alcoholic Fatty Liver ◽  
Term Efficacy ◽  
Alcoholic Fatty Liver Disease

scholarly journals Long-Term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis

2020 ◽  
Author(s):  
Evan S. Dellon ◽  
Margaret H. Collins ◽  
Marc E. Rothenberg ◽  
Yehudith Assouline-Dayan ◽  
Larry Evans ◽  
...  
Keyword(s):  
Eosinophilic Esophagitis ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension ◽  
Extension Trial

815 - Long-Term Efficacy and Safety of CT-P13 after Switching from Originator Infliximab: Exploratory Subgroup Analyses in IBD in the Nor-Switch Extension Trial

2018 ◽  
Vol 154 (6) ◽  
pp. S-168 ◽  
Author(s):  
Kristin K. Joergensen ◽  
Guro L. Goll ◽  
Joe Sexton ◽  
Inge C. Olsen ◽  
Nils Bolstad ◽  
...  
Keyword(s):  
Efficacy And Safety ◽  
Term Efficacy ◽  
Subgroup Analyses ◽  
Extension Trial
Sign in / Sign up

Export Citation Format

Share Document